Viking Therapeutics, Inc.
2019 Q4 - 2025 Q4 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 3,343 | 0.0% | 95,034 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,477 | 0.0% | 94,264 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 2,405 | 0.0% | 90,750 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 2,181 | 0.0% | 90,320 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 3,634 | 0.0% | 90,320 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 3,717 | 0.0% | 58,710 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 3,112 | 0.0% | 58,710 | 6/30/2024 |
| 2023 Q4 | 2/9/2024 | 514 | 0.0% | 27,620 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 306 | 0.0% | 27,620 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 443 | 0.0% | 27,300 | 6/30/2023 |
| 2022 Q1 | 5/6/2022 | 67 | 0.0% | 22,331 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 103 | 0.0% | 22,331 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 139 | 0.0% | 22,122 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 133 | 0.0% | 22,122 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 139 | 0.0% | 22,022 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 124 | 0.0% | 22,022 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 128 | 0.0% | 22,022 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 159 | 0.0% | 22,022 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 103 | 0.0% | 22,022 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 177 | 0.0% | 22,022 | 12/31/2019 |